DK0819002T3 - Anvendelse af imidazo-[1,2-a]pyridin-3-acetamidderivater til den terapeutiske behandling af neuropsykiatriske syndromer, der er forbundet med dysfunktion af nervebanerne i basalganglierne - Google Patents

Anvendelse af imidazo-[1,2-a]pyridin-3-acetamidderivater til den terapeutiske behandling af neuropsykiatriske syndromer, der er forbundet med dysfunktion af nervebanerne i basalganglierne

Info

Publication number
DK0819002T3
DK0819002T3 DK96907656T DK96907656T DK0819002T3 DK 0819002 T3 DK0819002 T3 DK 0819002T3 DK 96907656 T DK96907656 T DK 96907656T DK 96907656 T DK96907656 T DK 96907656T DK 0819002 T3 DK0819002 T3 DK 0819002T3
Authority
DK
Denmark
Prior art keywords
imidazo
dysfunction
pyridine
therapeutic treatment
basal ganglia
Prior art date
Application number
DK96907656T
Other languages
Danish (da)
English (en)
Inventor
Elena Benincasa
Original Assignee
Clarendon Trading & Investimen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarendon Trading & Investimen filed Critical Clarendon Trading & Investimen
Application granted granted Critical
Publication of DK0819002T3 publication Critical patent/DK0819002T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96907656T 1995-04-07 1996-04-02 Anvendelse af imidazo-[1,2-a]pyridin-3-acetamidderivater til den terapeutiske behandling af neuropsykiatriske syndromer, der er forbundet med dysfunktion af nervebanerne i basalganglierne DK0819002T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95RM000223A IT1276522B1 (it) 1995-04-07 1995-04-07 Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
PCT/IT1996/000063 WO1996031210A1 (fr) 1995-04-07 1996-04-02 UTILISATION DE DERIVES D'IMIDAZO(1,2-a)PYRIDINE-3-ACETAMIDE DANS LE TRAITEMENT THERAPEUTIQUE DES SYNDROMES NEUROPSYCHIATRIQUES ASSOCIES AU DYSFONCTIONNEMENT DES CIRCUITS NEURONAUX DES NOYAUX GRIS CENTRAUX

Publications (1)

Publication Number Publication Date
DK0819002T3 true DK0819002T3 (da) 2003-01-06

Family

ID=11403250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907656T DK0819002T3 (da) 1995-04-07 1996-04-02 Anvendelse af imidazo-[1,2-a]pyridin-3-acetamidderivater til den terapeutiske behandling af neuropsykiatriske syndromer, der er forbundet med dysfunktion af nervebanerne i basalganglierne

Country Status (25)

Country Link
US (1) US5891891A (fr)
EP (1) EP0819002B1 (fr)
JP (1) JP4049390B2 (fr)
KR (1) KR100425628B1 (fr)
CN (1) CN1198612C (fr)
AR (1) AR003414A1 (fr)
AT (1) ATE222763T1 (fr)
AU (1) AU707759B2 (fr)
CA (1) CA2217590C (fr)
CZ (1) CZ292020B6 (fr)
DE (1) DE69623271T2 (fr)
DK (1) DK0819002T3 (fr)
EA (1) EA000396B1 (fr)
ES (1) ES2182967T3 (fr)
HU (1) HUP9900733A3 (fr)
IL (1) IL117824A (fr)
IT (1) IT1276522B1 (fr)
MX (1) MX9707712A (fr)
NO (1) NO315408B1 (fr)
NZ (1) NZ304107A (fr)
PL (1) PL322647A1 (fr)
PT (1) PT819002E (fr)
TW (1) TW450816B (fr)
WO (1) WO1996031210A1 (fr)
ZA (1) ZA962711B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6333345B1 (en) 1999-05-14 2001-12-25 Sepracor, Inc. Methods of using and compositions comprising N-desmethylzolpidem
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
ATE335481T1 (de) * 2000-04-24 2006-09-15 Teva Pharma Zolpidem hemitartrat solvat
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10117183A1 (de) * 2001-04-05 2002-10-10 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
CA2526458A1 (fr) * 2003-05-19 2004-11-25 Sciencom Ltd Utilisation therapeutique supplementaire du zolpidem
GB0311457D0 (en) * 2003-05-19 2003-06-25 Sciencom Ltd New therapeutic use
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
JP2007523165A (ja) 2004-02-18 2007-08-16 セプレイコー インコーポレイテッド 睡眠の質を改善するためのドーパミン作動薬併用療法
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US8148393B2 (en) * 2005-11-18 2012-04-03 Synthon Bv Zolpidem tablets
GB2443928A (en) * 2006-11-08 2008-05-21 Regen Therapeutics Plc Transdermal pharmaceutical composition comprising Zolpidem
GB0809936D0 (en) * 2008-05-30 2008-07-09 Regen Therapeutics Plc Therapeutic use of zolpidem
EP3468545A4 (fr) 2016-06-08 2020-07-22 President and Fellows of Harvard College Procédés et compositions pour réduire le dysfonctionnement tactile et l'anxiété associés au trouble du spectre de l'autisme, au syndrome de rett et au syndrome de l'x fragile
AU2019272778B2 (en) 2018-05-22 2024-10-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
AU2019279858A1 (en) 2018-05-29 2020-11-26 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
EP3946390A4 (fr) 2019-03-25 2022-12-21 President and Fellows of Harvard College Compositions et méthodes pour réduire un dysfonctionnement tactile, l'anxiété et une déficience sociale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US5032595A (en) * 1989-11-24 1991-07-16 Fidia-Georgetown Institute For The Neurosciences Method of stimulating steroidogenesis with alpidem
US5206382A (en) * 1991-06-27 1993-04-27 Fidia Georgetown Institute For The Neurosciences Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders

Also Published As

Publication number Publication date
ITRM950223A0 (it) 1995-04-07
ITRM950223A1 (it) 1996-10-07
CN1183719A (zh) 1998-06-03
EP0819002A1 (fr) 1998-01-21
KR19980703707A (ko) 1998-12-05
HUP9900733A2 (hu) 1999-07-28
CA2217590A1 (fr) 1996-10-10
ES2182967T3 (es) 2003-03-16
US5891891A (en) 1999-04-06
EA000396B1 (ru) 1999-06-24
CA2217590C (fr) 2008-08-12
KR100425628B1 (ko) 2004-06-23
DE69623271D1 (de) 2002-10-02
IT1276522B1 (it) 1997-10-31
JP4049390B2 (ja) 2008-02-20
CZ292020B6 (cs) 2003-07-16
AR003414A1 (es) 1998-08-05
ATE222763T1 (de) 2002-09-15
JPH11503149A (ja) 1999-03-23
NO315408B1 (no) 2003-09-01
TW450816B (en) 2001-08-21
ZA962711B (en) 1996-07-30
DE69623271T2 (de) 2003-07-24
PL322647A1 (en) 1998-02-16
EA199700308A1 (ru) 1998-04-30
IL117824A0 (en) 1996-08-04
CZ316797A3 (cs) 1998-05-13
IL117824A (en) 2000-08-31
PT819002E (pt) 2003-01-31
HUP9900733A3 (en) 2003-05-28
AU5120096A (en) 1996-10-23
EP0819002B1 (fr) 2002-08-28
NZ304107A (en) 2000-12-22
NO974603L (no) 1997-11-24
WO1996031210A1 (fr) 1996-10-10
NO974603D0 (no) 1997-10-06
CN1198612C (zh) 2005-04-27
AU707759B2 (en) 1999-07-22
MX9707712A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
DK0819002T3 (da) Anvendelse af imidazo-[1,2-a]pyridin-3-acetamidderivater til den terapeutiske behandling af neuropsykiatriske syndromer, der er forbundet med dysfunktion af nervebanerne i basalganglierne
NL930044I1 (nl) Imidazo [1,2-a] pyridinederivaten de bereiding hiervan en de therapeutische toepassing
HU9401317D0 (en) Antiviral 2-ethyl - 1h imidazo (4,5-c) quinolin-4-amines
HU0103927D0 (en) Intermediates of pyrrolo[2,3-d]pyrimidine derivatives and process for the preparation thereof
ES8308327A1 (es) Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona.
ZA897699B (en) Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
FI922848L (fi) Menetelmä valmistaa terapeuttisesti aktiivisia tetrahydropyrrolo[1,2-a]pyratsiini-4-spiro-3'-pyrrolidiinijohdannaisia
UA27252C2 (uk) Похідні піразоло[1,5-а]піридину, які є антагоністами аденозину, та спосіб їх отримання
NO20013645D0 (no) Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjonen av perifere benzodiazepinreseptorer
ZA898074B (en) Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
DE69908608D1 (de) Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten
NO950202L (no) Tetracykliske forbindelser, fremgangsmåter og intermediater for fremstilling og anvendelse derav
FI952249L (fi) 5,6-dihydro-4H-imidatso/2'1':2,3/imidatso/4,5,1-ij/kinoliini ja 4,5-dihydroimidatso/1,2-a/pyrrolo/1,2,3-cd/-bentsimidatsolijohdannaiset, niiden valmistus ja terapeuttinen käyttö
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
FI884017A7 (fi) Pyrrolo /1,2-a/ imidatsoli- ja imidatso /1,2-a/-pyridiinijohdannaisia ja niiden käyttö 5-lipoksigenaasijohtoradan inhibiittoreina.
FI98816B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroimidatso [4,5,1-jk][1,4]bentsodiatsepin-2-oni ja -2-tionijohdannaisten valmistamiseksi
DK0399653T3 (da) Triazolo(4,5-c)pyridinderivater med antikrampe virkning
NO163530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-substituerte-5-fenyltetrazolo-(1,5-a) (1,2,4)-triazolo(1,5-c)pyrimidiner.
MX9707379A (es) Derivados de imidazo[1,2-a]piridina.